Mirati Therapeutics, Inc. 4
4 · Mirati Therapeutics, Inc. · Filed Oct 5, 2016
Insider Transaction Report
Form 4
LEMASTERS CHRISTOPHER C.
EVP, Chief Business Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2016-10-03+120,000→ 120,000 totalExercise: $6.45Exp: 2026-10-02→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.